参考文献/References:
[1] Madhavan MV,Tarigopula M,Mintz GS,et al. Coronary artery calcification:pathogenesis and prognostic implications[J]. J Am Coll Cardiol,2014,63(17):1703-1714.
[2] 王伟民,霍勇,葛均波. 冠状动脉钙化病变诊治中国专家共识(2021版) [J]. 中国介入心脏病学杂志,2021,29(5):251-259.
[3] Lawton JS,Tamis-Holland JE,Bangalore S,et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization:a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation,2022,145(3):e18-e114.
[4] Gialluisi A,Santoro A,Tirozzi A,et al. Epidemiological and genetic overlap among biological aging clocks:new challenges in biogerontology[J]. Ageing Res Rev,2021,72:101502.
[5] Duan R,Fu Q,Sun Y,et al. Epigenetic clock:a promising biomarker and practical tool in aging[J]. Ageing Res Rev ,2022,81:101743.
[6] Levine ME,Lu AT,Quach A,et al. An epigenetic biomarker of aging for lifespan and healthspan[J]. Aging(Albany NY),2018,10(4):573-591.
[7] Murthy M,Rizzu P,Heutink P,et al. Epigenetic age acceleration in frontotemporal lobar degeneration:a comprehensive analysis in the blood and brain[J]. Cells,2023,12(14):1922.
[8] Vaccarino V,Huang M,Wang Z,et al. Epigenetic age acceleration and cognitive decline:a twin study[J]. J Gerontol A Biol Sci Med Sci,2021,76(10):1854-1863.
[9] Liu Z,Kuo PL,Horvath S,et al. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV:a cohort study[J]. PLoS Med ,2018,15(12):e1002718.
[10] 徐国宾. 糖尿病诊断标准的完善及糖化血红蛋白A1c检测的标准化[J]. 临床检验杂志,2012,30(6):401-405.
[11] 陈建华,宋和平,陆瑾. 国内外高血压诊断标准比较[J]. 中西医结合心脑血管病杂志,2014,(5):527-528.
[12] 赵安琪,杨玲,查晴,等. 血清艾帕素-12水平与冠状动脉钙化的相关性研究[J]. 内科理论与实践,2024,19(2):107-114.
[13] 王仁辉,于子翔,程琦,等. 严重冠状动脉钙化病变患者行冠状动脉旋磨术后远期预后预测模型建立与评价[J]. 中国心血管病研究,2024,22(5):433-440.
[14] Inkster AM,Duarte-Guterman P,Albert AY,et al. Are sex differences in cognitive impairment reflected in epigenetic age acceleration metrics?[J]. Neurobiol Aging,2022,109:192-194.
[15] 刘玉玲. 表观遗传年龄加速度在冠心病队列中与血浆代谢物、冠心病相关疾病和预后的研究[D]. 华南理工大学 ,2022.
相似文献/References:
[1]刘强,杨小梅,韩乾国.冠状动脉钙化研究进展[J].心血管病学进展,2015,(5):651.[doi:10.3969/j.issn.1004-3934.2015.05.033]
LIU Qiang,YANG Xiaomei,HAN Qianguo.Progress in Clinical Application of Coronary Artery Calcification[J].Advances in Cardiovascular Diseases,2015,(4):651.[doi:10.3969/j.issn.1004-3934.2015.05.033]
[2]张丽娟 熊峰.冠状动脉钙化的影像学评估及临床应用价值进展[J].心血管病学进展,2019,(5):789.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.031]
of Coronary Artery Calcification.Imaging Evaluation and C linical Application[J].Advances in Cardiovascular Diseases,2019,(4):789.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.031]
[3]郑剑峰 邱洪.冠状动脉钙化研究进展[J].心血管病学进展,2020,(4):338.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.002]
ZHENG JianFengQIU Hong.Coronary Artery Calcification[J].Advances in Cardiovascular Diseases,2020,(4):338.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.002]
[4]马雅楠 金晓雪 刘德敏 卢蕊 谷国强.CTRP9对冠心病合并2型糖尿病患者冠状动脉钙化的预测价值[J].心血管病学进展,2022,(6):572.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.021]
MA Yanan,JIN Xiaoxue,LIU Demin,et al.Predictive Value of CTRP9 on Coronary Artery Calcification in Patients with Coronary Heart Disease Complicated with Type 2 Diabetes Mellitu[J].Advances in Cardiovascular Diseases,2022,(4):572.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.021]
[5]谭思华 周晓莉.非酒精性脂肪肝与冠状动脉粥样硬化及炎症的研究进展[J].心血管病学进展,2023,(5):439.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.013]
TAN Sihua,ZHOU Xiaoli.Association of Non-Alcoholic Fatty Liver Disease with Coronary Atherosclerosis and Inflammation[J].Advances in Cardiovascular Diseases,2023,(4):439.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.013]